Host genetic polymorphism analysis in cervical cancer

Clinical Chemistry

Volumn 48, Issue 8, 2002, Pages 1218-1224

  Calhoun, Eric S ^a   McGovern, Renee M ^a   Janney, Carol A ^a   Cerhan, James R ^a   Iturria, Stephen J ^a   Smith, David I ^a   Gostout, Bobbie S ^a   Persing, David H ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENOMIC DNA; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0036320869     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.8.1218     Document Type: Article

References (54)

1. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
2. Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer
3. Cancer statistics, 1999
4. Oncogenic DNA viruses
5. Cervical carcinoma and human papillomavirus: On the road to preventing a major human cancer
6. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
7. HPV for cervical cancer screening: Is the era of the molecular pap smear upon us?
8. Persistence of type-specific human papillomavirus infection among cytologically normal women
9. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
10. HPV testing: Where are we now?
11. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
12. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study
13. Cervical cancer in older women: A molecular analysis of human papillomavirus types, HLA types, and p53 mutations
14. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women
15. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women
16. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: Results from a population-based study in Costa Rica
17. Influence of TNFα gene polymorphisms on TNFα production and disease
18. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer
19. The genomics and genetics of human infectious disease susceptibility
20. Genetic dissection of the molecular pathogenesis of severe infection
21. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
22. Natural resistance to infection with intracellular pathogens: The Nramp1 protein is recruited to the membrane of the phagosome
23. The Nramp1 protein and its role in resistance to infection and macrophage function
24. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor
25. Immunogenetics and genomics
26. Science, medicine, and the future: Susceptibility to infection
27. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
28. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
29. Genetics of resistance to infection with Salmonella typhimurium in mice
30. Regulation of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to Leishmania donovani infection
31. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice
32. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family
33. 3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans
34. Biology of anogenital neoplasia
35. Th1 cytokine patterns in cervical human papillomavirus infection
36. Codon 72 polymorphism of p53 and its association with cervical cancer
37. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intra-epithelial lesions and invasive cancer of the uterine cervix
38. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation
39. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women
40. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer
41. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer
42. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
43. Tumor necrosis factor α promoter polymorphism at position -238 is associated with chronic active hepatitis C infection
44. A tumor necrosis factor-α (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection
45. The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers
46. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-α promoter
47. Genetic control of resistance to Salmonella typhimurium infection in high and low antibody responder mice
48. Regulation of resistance to leprosy by chromosome 1 locus in the mouse
49. Genetic regulation of resistance to intracellular pathogens
50. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression
51. Natural resistance to intracellular infections: Natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane
52. p53 codon 72 polymorphism and risk of cervical cancer in UK
53. Polymorphisms in candidate asthma genes